Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Modeling hyperactivity: of mice and men.

Literature DB >> 21546967

Modeling hyperactivity: of mice and men.

Yong-Seok Lee, Alcino J Silva.

Abstract

Entities: Disease Species

Mesh：

Substances：

Year: 2011 PMID： 21546967 DOI： 10.1038/nm0511-541

Source DB: PubMed Journal: Nat Med ISSN： 1078-8956 Impact factor: 53.440

× No keyword cloud information.

11 in total

1. A genomewide scan for attention-deficit/hyperactivity disorder in an extended sample: suggestive linkage on 17p11.

Authors: Matthew N Ogdie; I Laurence Macphie; Sonia L Minassian; May Yang; Simon E Fisher; Clyde Francks; Rita M Cantor; James T McCracken; James J McGough; Stanley F Nelson; Anthony P Monaco; Susan L Smalley
Journal: Am J Hum Genet Date: 2003-04-08 Impact factor: 11.025

2. The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1.

Authors: Weidong Li; Yijun Cui; Steven A Kushner; Robert A M Brown; J David Jentsch; Paul W Frankland; Tyrone D Cannon; Alcino J Silva
Journal: Curr Biol Date: 2005-11-08 Impact factor: 10.834

Review 3. Molecular genetics of attention-deficit/hyperactivity disorder.

Authors: Stephen V Faraone; Roy H Perlis; Alysa E Doyle; Jordan W Smoller; Jennifer J Goralnick; Meredith A Holmgren; Pamela Sklar
Journal: Biol Psychiatry Date: 2005-01-21 Impact factor: 13.382

Review 4. The multifunctional GIT family of proteins.

Authors: Ryan J Hoefen; Bradford C Berk
Journal: J Cell Sci Date: 2006-04-15 Impact factor: 5.285

5. Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome.

Authors: Fabian Fernandez; Wade Morishita; Elizabeth Zuniga; James Nguyen; Martina Blank; Robert C Malenka; Craig C Garner
Journal: Nat Neurosci Date: 2007-02-25 Impact factor: 24.884

Review 6. Rodent models of attention-deficit/hyperactivity disorder.

Authors: Terje Sagvolden; Vivienne A Russell; Heidi Aase; Espen Borgå Johansen; Mehdi Farshbaf
Journal: Biol Psychiatry Date: 2005-06-01 Impact factor: 13.382

7. A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease.

Authors: Heike Goehler; Maciej Lalowski; Ulrich Stelzl; Stephanie Waelter; Martin Stroedicke; Uwe Worm; Anja Droege; Katrin S Lindenberg; Maria Knoblich; Christian Haenig; Martin Herbst; Jaana Suopanki; Eberhard Scherzinger; Claudia Abraham; Bianca Bauer; Renate Hasenbank; Anja Fritzsche; Andreas H Ludewig; Konrad Büssow; Konrad Buessow; Sarah H Coleman; Claire-Anne Gutekunst; Bernhard G Landwehrmeyer; Hans Lehrach; Erich E Wanker
Journal: Mol Cell Date: 2004-09-24 Impact factor: 17.970

Modeling hyperactivity: of mice and men.

1. A genomewide scan for attention-deficit/hyperactivity disorder in an extended sample: suggestive linkage on 17p11.

2. The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1.

Review 3. Molecular genetics of attention-deficit/hyperactivity disorder.

Review 4. The multifunctional GIT family of proteins.

5. Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome.

Review 6. Rodent models of attention-deficit/hyperactivity disorder.

7. A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease.

8. Neurofibromin regulation of ERK signaling modulates GABA release and learning.

9. Impaired fear response in mice lacking GIT1.

10. Impaired spine formation and learning in GPCR kinase 2 interacting protein-1 (GIT1) knockout mice.

Review 1. Genes and signaling pathways involved in memory enhancement in mutant mice.

2. GIT1 regulates synaptic structural plasticity underlying learning.